Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting, 14175 [2010-6438]

Download as PDF Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Council on Blood Stem Cell Transplantation; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: srobinson on DSKHWCL6B1PROD with NOTICES Name: Advisory Council on Blood Stem Cell Transplantation. Date and Times: May 5, 2010, 8:30 a.m. to 4:30 p.m. Place: Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, Bethesda, Maryland 20852. Status: The meeting will be open to the public. Purpose: Pursuant to Public Law 109–129, 42 U.S.C. 274k (section 379 of the Public Health Service Act, as amended) the ACBSCT advises the Secretary of HHS and the Administrator, HRSA, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program (Program) and the National Cord Blood Inventory (NCBI) Program. ACBSCT is composed of up to 25 members, including the Chair, serving as Special Government Employees. The current membership includes representatives of marrow donor centers and marrow transplant centers; representatives of cord blood banks and participating birthing hospitals; recipients of a bone marrow transplant; recipients of a cord blood transplant; persons who require such transplants; family members of such a recipient or family members of a patient who has requested the assistance of the Program in searching for an unrelated donor of bone marrow or cord blood; persons with expertise in bone marrow and cord blood transplantation; persons with expertise in typing, matching, and transplant outcome data analysis; persons with expertise in the social sciences; basic scientists with expertise in the biology of adult stem cells; ethicists; hematology and transfusion medicine researchers with expertise in adult blood stem cells; persons with expertise in cord blood processing; and members of the general public. Agenda The Council will hear reports from three ACBSCT Work Groups: Access to Transplantation, Cord Blood Collections, and Scientific Factors Necessary To Define a Cord Blood Unit as High Quality. The Council also will hear presentations and discussions on the following topics: Performance measures and targets for programs, FDA final guidance for cord blood licensure, models predicting the impact of growth of the cord blood inventory and the adult donor registry, realizing the full potential of cord blood, financial incentives for adult donors, and the capacity of the national system to handle a larger number of transplants. Agenda items are subject to change as priorities indicate. After the presentations and Council discussions, members of the public will have VerDate Nov<24>2008 16:24 Mar 23, 2010 Jkt 220001 an opportunity to provide comments. Because of the Council’s full agenda and the timeframe in which to cover the agenda topics, public comment will be limited. All public comments will be included in the record of the ACBSCT meeting. Meeting summary notes will be made available on the HRSA’s Program Web site at http:// bloodcell.transplant.hrsa.gov/ABOUT/ Advisory_Council/index.html. The draft meeting agenda and a registration form are available on the HRSA’s Program Web site at http:// bloodcell.transplant.hrsa.gov/ABOUT/ Advisory_Council/index.html. Registration can also be completed electronically at http://www.ACBSCT.com or submitted by facsimile to Lux Consulting Group, Inc., the logistical support contractor for the meeting, at fax number (301) 585– 7741, ATTN: Tristan Alexander. Individuals without access to the Internet who wish to register may call Tristan Alexander at (301) 585–1261. For Further Information Contact: Remy Aronoff, Executive Secretary, Healthcare Systems Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Room 12–105, Rockville, Maryland 20857; telephone (301) 443–3264. Dated: March 16, 2010. Sahira Rafiullah, Director, Division of Policy and Information Coordination. [FR Doc. 2010–6438 Filed 3–23–10; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting 14175 such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering; NACBIB, May, 2010. Date: May 21, 2010. Open: 8:30 a.m. to 12:15 p.m. Agenda: Report from the Institute Director, other Institute Staff and presentations of working group reports. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level), Bethesda, MD 20817. Closed: 1:30 p.m. to 3 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level), Bethesda, MD 20817. Contact Person: Anthony Demsey, PhD, Director, National Institute of Biomedical Imaging, and Bioengineering, 6701 Democracy Boulevard, Room 241, Bethesda, MD 20892. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: http:// www.nibib1.nih.gov/about/NACBIB/ NACBIB.htm, where an agenda and any additional information for the meeting will be posted when available. Dated: March 17, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–6436 Filed 3–23–10; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 75, Number 56 (Wednesday, March 24, 2010)]
[Notices]
[Page 14175]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6438]



[[Page 14175]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Council on Blood Stem Cell Transplantation; Notice of 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Council on Blood Stem Cell Transplantation.
    Date and Times: May 5, 2010, 8:30 a.m. to 4:30 p.m.
    Place: Bethesda North Marriott Hotel and Conference Center, 5701 
Marinelli Road, Bethesda, Maryland 20852.
    Status: The meeting will be open to the public.
    Purpose: Pursuant to Public Law 109-129, 42 U.S.C. 274k (section 
379 of the Public Health Service Act, as amended) the ACBSCT advises 
the Secretary of HHS and the Administrator, HRSA, on matters related 
to the activities of the C.W. Bill Young Cell Transplantation 
Program (Program) and the National Cord Blood Inventory (NCBI) 
Program. ACBSCT is composed of up to 25 members, including the 
Chair, serving as Special Government Employees. The current 
membership includes representatives of marrow donor centers and 
marrow transplant centers; representatives of cord blood banks and 
participating birthing hospitals; recipients of a bone marrow 
transplant; recipients of a cord blood transplant; persons who 
require such transplants; family members of such a recipient or 
family members of a patient who has requested the assistance of the 
Program in searching for an unrelated donor of bone marrow or cord 
blood; persons with expertise in bone marrow and cord blood 
transplantation; persons with expertise in typing, matching, and 
transplant outcome data analysis; persons with expertise in the 
social sciences; basic scientists with expertise in the biology of 
adult stem cells; ethicists; hematology and transfusion medicine 
researchers with expertise in adult blood stem cells; persons with 
expertise in cord blood processing; and members of the general 
public.

Agenda

    The Council will hear reports from three ACBSCT Work Groups: 
Access to Transplantation, Cord Blood Collections, and Scientific 
Factors Necessary To Define a Cord Blood Unit as High Quality. The 
Council also will hear presentations and discussions on the 
following topics: Performance measures and targets for programs, FDA 
final guidance for cord blood licensure, models predicting the 
impact of growth of the cord blood inventory and the adult donor 
registry, realizing the full potential of cord blood, financial 
incentives for adult donors, and the capacity of the national system 
to handle a larger number of transplants. Agenda items are subject 
to change as priorities indicate.
    After the presentations and Council discussions, members of the 
public will have an opportunity to provide comments. Because of the 
Council's full agenda and the timeframe in which to cover the agenda 
topics, public comment will be limited. All public comments will be 
included in the record of the ACBSCT meeting. Meeting summary notes 
will be made available on the HRSA's Program Web site at http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html.
    The draft meeting agenda and a registration form are available 
on the HRSA's Program Web site at http://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html.
    Registration can also be completed electronically at http://www.ACBSCT.com or submitted by facsimile to Lux Consulting Group, 
Inc., the logistical support contractor for the meeting, at fax 
number (301) 585-7741, ATTN: Tristan Alexander. Individuals without 
access to the Internet who wish to register may call Tristan 
Alexander at (301) 585-1261.
    For Further Information Contact: Remy Aronoff, Executive Secretary, 
Healthcare Systems Bureau, Health Resources and Services 
Administration, 5600 Fishers Lane, Room 12-105, Rockville, Maryland 
20857; telephone (301) 443-3264.

    Dated: March 16, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information Coordination.
[FR Doc. 2010-6438 Filed 3-23-10; 8:45 am]
BILLING CODE 4165-15-P